Greg Madison, President and CEO at KERYX BIOPHARMACEUTICALS INC (KERX), bought 9,984 shares at $5.69 ($57K) on 2015-08-20, disclosed to the SEC on 2015-08-24.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| Filing → |
| KERX | SELL | 2017-10-31 | $24K | — | Filing → |
| KERX | SELL | 2017-10-06 | $6K | — | Filing → |
| KERX | SELL | 2017-08-01 | $29K | — | Filing → |